Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Inhibrx Inc (INBX)

Inhibrx Inc (INBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,615,593
  • Shares Outstanding, K 47,392
  • Annual Sales, $ 1,800 K
  • Annual Income, $ -241,360 K
  • 60-Month Beta 2.91
  • Price/Sales 905.19
  • Price/Cash Flow N/A
  • Price/Book 37.10
Trade INBX with:

Options Overview Details

View History
  • Implied Volatility 51.13% ( -0.17%)
  • Historical Volatility 7.65%
  • IV Percentile 24%
  • IV Rank 13.76%
  • IV High 278.66% on 12/26/23
  • IV Low 14.83% on 03/22/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 62
  • Volume Avg (30-Day) 76
  • Put/Call OI Ratio 1.44
  • Today's Open Interest 2,440
  • Open Int (30-Day) 2,507

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -1.12
  • Growth Rate Est. (year over year) +89,296.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
33.72 +0.99%
on 04/26/24
35.42 -3.84%
on 04/11/24
-1.01 (-2.88%)
since 03/26/24
3-Month
33.72 +0.99%
on 04/26/24
39.79 -14.40%
on 02/27/24
-3.54 (-9.41%)
since 01/26/24
52-Week
14.31 +138.10%
on 10/31/23
39.79 -14.40%
on 02/27/24
+14.11 (+70.73%)
since 04/26/23

Most Recent Stories

More News
Inhibrx Announces Participation in Upcoming Scientific Conferences

/PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX), a clinical-stage biopharmaceutical company dedicated to the development of therapeutics for oncology and rare...

INBX : 34.06 (-0.09%)
Inhibrx Retains Rights to INBRX-101 for the Treatment of Alpha-1 Antitrypsin Deficiency Outside of the United States and Canada

/PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX), a clinical-stage biopharmaceutical company dedicated to the development of therapeutics for oncology and rare...

INBX : 34.06 (-0.09%)
Inhibrx Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights

/PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX), or Inhibrx, or the Company, a biopharmaceutical company with four programs in ongoing clinical trials and a...

INBX : 34.06 (-0.09%)
Inhibrx, Inc. (INBX) Reports Q1 Loss, Lags Revenue Estimates

Inhibrx, Inc. (INBX) delivered earnings and revenue surprises of -33.33% and 94.33%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

INBX : 34.06 (-0.09%)
AGEN : 11.69 (+40.84%)
Inhibrx Reports First Quarter 2023 Financial Results and Recent Corporate Highlights

/PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX), or Inhibrx, or the Company, a biopharmaceutical company with four clinical programs in development and a strong...

INBX : 34.06 (-0.09%)
Strength Seen in Inhibrx, Inc. (INBX): Can Its 9.9% Jump Turn into More Strength?

Inhibrx, Inc. (INBX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase...

INBX : 34.06 (-0.09%)
ZLAB : 15.91 (+1.08%)
Inhibrx, Inc. (INBX) Reports Q4 Loss, Misses Revenue Estimates

Inhibrx, Inc. (INBX) delivered earnings and revenue surprises of -18.75% and 8.67%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

INBX : 34.06 (-0.09%)
AEZS : 1.9562 (-0.19%)
Inhibrx Reports Fourth Quarter and Fiscal Year 2022 Financial Results

/PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a biopharmaceutical company with four clinical programs in development and a strong...

INBX : 34.06 (-0.09%)
NorthStar Medical Radioisotopes and Inhibrx Enter into Collaboration Agreement for the Development and Production of Radiopharmaceutical Candidates

/PRNewswire/ -- NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for...

INBX : 34.06 (-0.09%)
NorthStar Medical Radioisotopes and Inhibrx Enter into Collaboration Agreement for the Development and Production of Radiopharmaceutical Candidates

NorthStar Medical Radioisotopes , LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, and Inhibrx,...

INBX : 34.06 (-0.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Inhibrx Inc. is a clinical-stage biotechnology company. The company's pipeline is focused on oncology and orphan diseases. Inhibrx Inc. is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 34.66
2nd Resistance Point 34.40
1st Resistance Point 34.23
Last Price 34.06
1st Support Level 33.81
2nd Support Level 33.55
3rd Support Level 33.38

See More

52-Week High 39.79
Last Price 34.06
Fibonacci 61.8% 30.05
Fibonacci 50% 27.05
Fibonacci 38.2% 24.04
52-Week Low 14.31

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar